ArticleCommunications medicine2026

Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progression.

Tereza Kacerova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.